Induction of metallothionein in mouse cerebellum and cerebrum with low-dose thimerosal injection
Authors:
- 9 April 2009
- journal article
- Published by Springer Nature in Cell Biology and Toxicology
- Vol. 26 (2) , 143-152
Abstract
Thimerosal, an ethyl mercury compound, is used worldwide as a vaccine preservative. We previously observed that the mercury concentration in mouse brains did not increase with the clinical dose of thimerosal injection, but the concentration increased in the brain after the injection of thimerosal with lipopolysaccharide, even if a low dose of thimerosal was administered. Thimerosal may penetrate the brain, but is undetectable when a clinical dose of thimerosal is injected; therefore, the induction of metallothionein (MT) messenger RNA (mRNA) and protein was observed in the cerebellum and cerebrum of mice after thimerosal injection, as MT is an inducible protein. MT-1 mRNA was expressed at 6 and 9 h in both the cerebrum and cerebellum, but MT-1 mRNA expression in the cerebellum was three times higher than that in the cerebrum after the injection of 12 microg/kg thimerosal. MT-2 mRNA was not expressed until 24 h in both organs. MT-3 mRNA was expressed in the cerebellum from 6 to 15 h after the injection, but not in the cerebrum until 24 h. MT-1 and MT-3 mRNAs were expressed in the cerebellum in a dose-dependent manner. Furthermore, MT-1 protein was detected from 6 to 72 h in the cerebellum after 12 microg/kg of thimerosal was injected and peaked at 10 h. MT-2 was detected in the cerebellum only at 10 h. In the cerebrum, little MT-1 protein was detected at 10 and 24 h, and there were no peaks of MT-2 protein in the cerebrum. In conclusion, MT-1 and MT-3 mRNAs but not MT-2 mRNA are easily expressed in the cerebellum rather than in the cerebrum by the injection of low-dose thimerosal. It is thought that the cerebellum is a sensitive organ against thimerosal. As a result of the present findings, in combination with the brain pathology observed in patients diagnosed with autism, the present study helps to support the possible biological plausibility for how low-dose exposure to mercury from thimerosal-containing vaccines may be associated with autism.Keywords
This publication has 60 references indexed in Scilit:
- An epidemiological analysis of the ‘autism as mercury poisoning’ hypothesisInternational Journal of Risk & Safety in Medicine, 2008
- Metallothionein and a peptide modeled after metallothionein, EmtinB, induce neuronal differentiation and survival through binding to receptors of the low‐density lipoprotein receptor familyJournal of Neurochemistry, 2007
- New insight into the molecular pathways of metallothionein‐mediated neuroprotection and regenerationJournal of Neurochemistry, 2007
- Is chemical neurotransmission altered specifically during methylmercury-induced cerebellar dysfunction?Trends in Pharmacological Sciences, 2005
- Comparison of Blood and Brain Mercury Levels in Infant Monkeys Exposed to Methylmercury or Vaccines Containing ThimerosalEnvironmental Health Perspectives, 2005
- Role of metallothionein-III following central nervous system damageNeurobiology of Disease, 2003
- Thimerosal Induces DNA Breaks, Caspase-3 Activation, Membrane Damage, and Cell Death in Cultured Human Neurons and FibroblastsToxicological Sciences, 2003
- The three modern faces of mercury.Environmental Health Perspectives, 2002
- Autism: a novel form of mercury poisoningMedical Hypotheses, 2001
- Methylmercury-induced inhibition of regulatory volume decrease in astrocytes: characterization of osmoregulator efflux and its reversal by amilorideBrain Research, 1998